204 related articles for article (PubMed ID: 31372790)
1. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.
Zhang L; Bailleul J; Yazal T; Dong K; Sung D; Dao A; Gosa L; Nathanson D; Bhat K; Duhachek-Muggy S; Alli C; Dratver MB; Pajonk F; Vlashi E
Breast Cancer Res Treat; 2019 Nov; 178(1):75-86. PubMed ID: 31372790
[TBL] [Abstract][Full Text] [Related]
2. Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes.
Apostolidi M; Vathiotis IA; Muthusamy V; Gaule P; Gassaway BM; Rimm DL; Rinehart J
Cancer Res; 2021 Aug; 81(16):4346-4359. PubMed ID: 34185676
[TBL] [Abstract][Full Text] [Related]
3. Suppressed "Warburg Effect" in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway.
Zhao P; Zhou M; Chen R; Su R
Technol Cancer Res Treat; 2020; 19():1533033820945804. PubMed ID: 32815467
[TBL] [Abstract][Full Text] [Related]
4. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305
[TBL] [Abstract][Full Text] [Related]
5. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.
Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM
PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-kB Activity in Triple-Negative Breast Cancer Cells.
Ma C; Zu X; Liu K; Bode AM; Dong Z; Liu Z; Kim DJ
Mol Cells; 2019 Sep; 42(9):628-636. PubMed ID: 31564074
[TBL] [Abstract][Full Text] [Related]
7. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
8. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.
Wen Y; Dai G; Wang L; Fu K; Zuo S
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842344
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K(3) and K(5) are inhibitors of tumor pyruvate kinase M2.
Chen J; Jiang Z; Wang B; Wang Y; Hu X
Cancer Lett; 2012 Mar; 316(2):204-10. PubMed ID: 22154083
[TBL] [Abstract][Full Text] [Related]
10. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin Superfamily Containing Leucine-Rich Repeat (ISLR) Serves as a Redox Sensor That Modulates Antioxidant Capacity by Suppressing Pyruvate Kinase Isozyme M2 Activity.
Wang T; Chen M; Su Y; Zhang Y; Liu C; Lan M; Li L; Liu F; Li N; Yu Y; Xiong L; Wang K; Liu J; Xu Q; Hu Y; Jia Y; Cao Y; Pan J; Meng Q
Cells; 2024 May; 13(10):. PubMed ID: 38786060
[TBL] [Abstract][Full Text] [Related]
12. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines.
Tahtouh R; Wardi L; Sarkis R; Hachem R; Raad I; El Zein N; Hilal G
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):26-33. PubMed ID: 31880514
[TBL] [Abstract][Full Text] [Related]
13. Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Giannoni E; Taddei ML; Morandi A; Comito G; Calvani M; Bianchini F; Richichi B; Raugei G; Wong N; Tang D; Chiarugi P
Oncotarget; 2015 Sep; 6(27):24061-74. PubMed ID: 26183399
[TBL] [Abstract][Full Text] [Related]
14. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis.
Arundhathi JRD; Mathur SR; Gogia A; Deo SVS; Mohapatra P; Prasad CP
Mol Biol Rep; 2021 May; 48(5):4733-4745. PubMed ID: 34047880
[TBL] [Abstract][Full Text] [Related]
15. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
[TBL] [Abstract][Full Text] [Related]
17. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential.
Pelicano H; Zhang W; Liu J; Hammoudi N; Dai J; Xu RH; Pusztai L; Huang P
Breast Cancer Res; 2014 Sep; 16(5):434. PubMed ID: 25209360
[TBL] [Abstract][Full Text] [Related]
19. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
20. Stable shRNA Silencing of Lactate Dehydrogenase A (LDHA) in Human MDA-MB-231 Breast Cancer Cells Fails to Alter Lactic Acid Production, Glycolytic Activity, ATP or Survival.
Mack N; Mazzio EA; Bauer D; Flores-Rozas H; Soliman KF
Anticancer Res; 2017 Mar; 37(3):1205-1212. PubMed ID: 28314283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]